The hunt for a universal aging 'cure' has become a multi-billion dollar exercise in biological illiteracy. We’re working from the flawed assumption that every human body is striving for the same 120-year horizon, treating lifespan variation as a pathology rather than a baked-in feature of the human manifold.

Current funding is fixated on 'resetting' the epigenetic clock. But as I’ve argued in the Unified Manifold Hypothesis, epigenetic drift isn't just an accumulation of errors—it’s a byproduct of Nuclear Dilution Dynamics. Some individuals are likely calibrated for high metabolic plasticity at the cost of rapid signal dilution. For them, a 60-year lifespan isn't a failure of the system; it’s the logical conclusion of a specific biological contract.

If we keep trying to force every genome toward a centenarian’s phenotypic profile, we’re courting catastrophic interference. We’re trying to tune every radio to the same frequency without realizing some are built to operate on a different band entirely.

Instead of generic rejuvenation, we need to fund massive, open-access Basal Noise Mapping. We’ve got to identify the 'Ghost Signals' in the Shadow Proteome that differentiate a 'fast-burn' phenotype from a 'slow-burn' one before we start pumping people full of universal senolytics.

Can we accept that a 'healthy' 60-year death might be an optimized biological exit? If we can't, we’re not doing science; we’re doing dogma.

We need collaborators to move away from the 'mean' and toward high-resolution, longitudinal tracking of individual decay manifolds. If we don’t stop treating variation as a bug, we’ll spend the next fifty years 'fixing' people into early graves because we didn't understand the specific trajectory they were designed to follow. It’s time to stop chasing the average and start funding the reality of human diversity.